Sort
53,477 grants matching “addiction”
Expanding Medication Assisted Therapy in Ukraine (ExMAT)
$769,707Frederick Lewis Altice · Yale University · R01 · FY2017 · DA
Anandamide Transport Inhibitors
$769,581Dale G Deutsch · State University New York Stony Brook · R01 · FY2013 · DA
Naltrexone for Opioid Dependent Released HIV+ Criminal Justice Populations
$769,553Sandra Ann Springer · Yale University · R01 · FY2013 · DA
Development of I-THP as New Medication for Drug Addiction (DP1)
$769,500Jia Bei Wang · University Of Maryland Baltimore · DP1 · FY2014 · DA
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network
$769,433Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2016 · DA
Cloud-based High-throughput Acquisition and Analytics of Zebrafish Electrocardiogram for Cardiac Studies and Drug Development
$769,421Michael P.h. Lau · Sensoriis, Inc. · R44 · FY2020 · OD
Cloud-based High-throughput Acquisition and Analytics of Zebrafish Electrocardiogram for Cardiac Studies and Drug Development
$769,421Michael P.h. Lau · Sensoriis, Inc. · R44 · FY2021 · OD
Understanding neuronal subtype-specific function of NAc in cocaine addiction
$769,403Yi Zhang · Boston Children'S Hospital · R01 · FY2021 · DA
Does medical cannabis reduce opioid analgesics in HIV+ and HIV- adults with pain?
$769,238Chinazo Cunningham · Albert Einstein College Of Medicine · R01 · FY2019 · DA
Implementation to motivate physician response to opioid dependence in HIVsetting
$769,194Peter D. Friedmann · Baystate Medical Center, Inc. · R01 · FY2015 · DA
Implementing statewide emergency department care pathways for addiction recovery after opioid overdose
$769,135Francesca Beaudoin · Rhode Island Hospital · R01 · FY2020 · CE
Peer Recovery Support Services for individuals in Recovery Residences on MOUD
$769,020Marc Fishman · Maryland Treatment Centers, Inc. · R34 · FY2022 · DA
Development of (R,R)-dehydronorketamine for treatment resistant depression
$768,952Craig Thomas · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR
Evolution and Clinical Relevance of SARS-CoV-2 Variants in West Virginia
$768,858Sally Lynn Hodder · West Virginia University · U54 · FY2022 · GM
Synthetic Psychoactive "Bath Salt" Effects on Brain Activity and Behavior
$768,824Stephen John Kohut · Mclean Hospital · R01 · FY2021 · DA
Using Sleep Health to Optimize Smoking Cessation Treatment Response in HIV-Positive Adults
$768,604Elizabeth Connick · University Of Arizona · R01 · FY2021 · DA
Psychosocial pain management to improve opioid use disorder treatment outcomes
$768,590Mark A. Ilgen · University Of Michigan At Ann Arbor · R33 · FY2019 · AT
Clinical Trials Network: The Texas Node
$768,586Madhukar H Trivedi · Ut Southwestern Medical Center · U10 · FY2013 · DA
Evaluation of the Smart Talk: Cannabis Awareness and Prevention Curriculum
$768,528Bonnie L Halpern-Felsher · Stanford University · R01 · FY2025 · DA
Brain mechanisms of reducing polysubstance use following a novel body-mind intervention
$768,501Yiyuan Tang · Arizona State University-Tempe Campus · R33 · FY2023 · AT
Squirrel Monkey Breeding and Research Resource
$768,371Lawrence E Williams · University Of Tx Md Anderson Can Ctr · P40 · FY2018 · OD
Squirrel Monkey Breeding and Research Resource
$768,371Lawrence E Williams · University Of Tx Md Anderson Can Ctr · P40 · FY2019 · OD
Squirrel Monkey Breeding and Research Resource
$768,371Christian R Abee · University Of Tx Md Anderson Can Ctr · P40 · FY2016 · OD
Monitoring the Future: Drug Use and Lifestyles of American Youth
$768,321Richard A Miech · University Of Michigan At Ann Arbor · R01 · FY2020 · DA
A revolutionary vaccine approach to prevent HIV infection in substance abuse
$768,300Stephen N. Waggoner · Cincinnati Childrens Hosp Med Ctr · DP1 · FY2015 · DA